Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. ENSPRYNG (satralizumab)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

ENSPRYNG (satralizumab)

Medicine - Posted on Feb 10 2022
Active substance (DCI)
  • satralizumab
history (1)
  • 1/17/22

    ENSPRYNG (satralizumab)

    Key points Favourable opinion for reimbursement as a monotherapy or in combination with immunosuppressive therapy (IST) for ...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • L04AC19
Manufacturer
ROCHE France
Presentation

ENSPRYNG 120 mg, solution injectable en seringue préremplie
B/1 - (Code CIP : 34009 302 344 3 3)

All our publications
    Autoimmune diseases Central nervous system diseases Congenital, genetic and rare diseases Demyelinating diseases Drug therapy Eye diseases Paediatrics

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
JmqghxZ1MEtVDFQf